Petros Pharmaceuticals inc (PTPI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PTPI Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Petros Pharmaceuticals inc's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent3.49
Cash & Short-term Investments3.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.06
Total Current Assets3.55
Prepaid Expense and Other Assets, Total0.00
Operating Lease Right Of Use Asset-
Total Assets3.55
Liabilities
Accounts Payable, Current AC0.10
Accrued Liabilities, Current AC0.22
Other Liabilities, Current2.53
Total Current Liabilities2.84
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Payable Preferred Stock Redeemed2.30
Total Liabilities2.84
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock113.93
Retained Earnings / Accumulated Deficit-113.24
Defined Benefit Plan and Other0.00
Other Equity0.00
Common Stockholder's Equity0.70
Total Stockholder's Equity0.70
Liabilities & Stockholder's Equity3.55
4 historic quarters locked

Sign in to unlock the full Petros Pharmaceuticals inc balance sheet history.

About Petros Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-095979

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.